DexCom Inc (NASDAQ:DXCM)
| 20.30 Data as of May 24 |  +0.03 / +0.15%Today’s Change | 10.30 Today|||52-Week Range 21.69 | +49.37% Year-to-Date |
Latest DXCM News | Press Releases
| DexCom Stays at Neutral - Analyst Blog May 23 / Zacks.com |
Today’s Trading
| Previous close | 20.27 |
| Today’s open | 20.22 |
| Day’s range | 20.06 - 20.42 |
| Volume | 332,520 |
| Average volume (3 months) | 497,950 |
| Market cap | $1.4B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -16.18% |
| Earnings growth (this year) | +28.13% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +30.99% |
| P/E ratio | NM |
| Price/Sales | 9.35 |
| Price/Book | 18.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GMEDGlobus Medical Inc | -0.14 | -0.91% |
| PODDInsulet Corp | +0.39 | +1.33% |
| MASIMasimo Corp | -0.13 | -0.60% |
| ICUIICU Medical Inc | +1.80 | +2.61% |
Data as of 4:03pm ET, 05/24/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $99.9M |
| Annual profit (last year) | -$54.5M |
| Net profit margin | -54.55% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Terry H. Gregg |
President, Chief Operating Officer & Director Kevin Ronald Sayer, CPA |
Corporate headquarters San Diego, California |
Forecasts
